| scholarly article | Q13442814 |
| P50 | author | Tanios Bekaii-Saab | Q43376169 |
| P2093 | author name string | Ramesh K Ramanathan | |
| Daniel H Ahn | |||
| P2860 | cites work | Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation | Q56240758 |
| Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma | Q56899396 | ||
| Prognostic significance of mast cell count following curative resection for pancreatic ductal adenocarcinoma | Q82938225 | ||
| Hedgehog signaling is restricted to the stromal compartment during pancreatic carcinogenesis | Q37110115 | ||
| Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a STAT3-dependent manner | Q37203714 | ||
| A phase I study of an agonist CD40 monoclonal antibody (CP-870,893) in combination with gemcitabine in patients with advanced pancreatic ductal adenocarcinoma | Q37325331 | ||
| Signal transduction in pancreatic stellate cells | Q37409275 | ||
| Identification of germline genetic mutations in patients with pancreatic cancer | Q37540235 | ||
| Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic | Q37826009 | ||
| Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer | Q37877648 | ||
| Therapeutic targeting of hyaluronan in the tumor stroma | Q38161392 | ||
| Bruton Tyrosine Kinase-Dependent Immune Cell Cross-talk Drives Pancreas Cancer. | Q38808099 | ||
| A Phase I Study of FOLFIRINOX Plus IPI-926, a Hedgehog Pathway Inhibitor, for Advanced Pancreatic Adenocarcinoma | Q38961784 | ||
| Biliary cancer: intrahepatic cholangiocarcinoma vs. extrahepatic cholangiocarcinoma vs. gallbladder cancers: classification and therapeutic implications | Q39289707 | ||
| STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis. | Q39540918 | ||
| Sonic hedgehog promotes desmoplasia in pancreatic cancer | Q39933626 | ||
| Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial | Q41090587 | ||
| Cancer-stellate cell interactions perpetuate the hypoxia-fibrosis cycle in pancreatic ductal adenocarcinoma | Q41768958 | ||
| Expression of transforming growth factor-beta 1 by pancreatic stellate cells and its implications for matrix secretion and turnover in chronic pancreatitis | Q42151300 | ||
| Immunologic and Metabolic Features of Pancreatic Ductal Adenocarcinoma Define Prognostic Subtypes of Disease. | Q42416539 | ||
| Enzymatic Depletion of Tumor Hyaluronan Induces Antitumor Responses in Preclinical Animal Models | Q42846593 | ||
| Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours | Q43837471 | ||
| Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%. | Q44049901 | ||
| A First-in-Human Phase I Study of the Anticancer Stem Cell Agent Ipafricept (OMP-54F28), a Decoy Receptor for Wnt Ligands, in Patients with Advanced Solid Tumors | Q46144795 | ||
| Ibrutinib exerts potent antifibrotic and antitumor activities in mouse models of pancreatic adenocarcinoma. | Q46681137 | ||
| HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal Adenocarcinoma. | Q47324527 | ||
| Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinoma | Q48575438 | ||
| The Bruton tyrosine kinase inhibitor PCI-32765 ameliorates autoimmune arthritis by inhibition of multiple effector cells | Q21195261 | ||
| Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer | Q24633070 | ||
| PARP Inhibitors for BRCA1/2 mutation-associated and BRCA-like malignancies | Q27027503 | ||
| Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer | Q27860857 | ||
| Identification of pancreatic cancer stem cells | Q28286997 | ||
| Cancer statistics, 2016 | Q29547383 | ||
| Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer | Q29547558 | ||
| FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer | Q29547638 | ||
| CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans | Q29614348 | ||
| Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma | Q29616287 | ||
| Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine | Q29616728 | ||
| Hallmarks of 'BRCAness' in sporadic cancers | Q29618825 | ||
| Immunosuppressive networks in the tumour environment and their therapeutic relevance | Q29619244 | ||
| Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse | Q29620396 | ||
| Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia | Q29620690 | ||
| Overexpression of smoothened activates the sonic hedgehog signaling pathway in pancreatic cancer-associated fibroblasts | Q30493907 | ||
| Crosstalk between mast cells and pancreatic cancer cells contributes to pancreatic tumor progression | Q30501621 | ||
| Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial. | Q33609699 | ||
| Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma | Q33896442 | ||
| ALDH Activity Selectively Defines an Enhanced Tumor-Initiating Cell Population Relative to CD133 Expression in Human Pancreatic Adenocarcinoma | Q33939548 | ||
| Stromal response to Hedgehog signaling restrains pancreatic cancer progression | Q34002580 | ||
| Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival | Q34269713 | ||
| An emerging entity: pancreatic adenocarcinoma associated with a known BRCA mutation: clinical descriptors, treatment implications, and future directions | Q34632472 | ||
| Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers | Q34663583 | ||
| Pancreatic stellate cells radioprotect pancreatic cancer cells through β1-integrin signaling. | Q34989886 | ||
| Suppression of cancer relapse and metastasis by inhibiting cancer stemness | Q35090120 | ||
| Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover | Q35598320 | ||
| Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer | Q35830110 | ||
| Poly(ADP-ribose) polymerase (PARP-1) in homologous recombination and as a target for cancer therapy | Q36241184 | ||
| Role of janus kinase/signal transducers and activators of transcription in the pathogenesis of pancreatitis and pancreatic cancer. | Q36385146 | ||
| Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses | Q36586333 | ||
| Stromal biology of pancreatic cancer | Q36723725 | ||
| Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis | Q36980064 | ||
| CD40 Stimulation Obviates Innate Sensors and Drives T Cell Immunity in Cancer | Q37029731 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P921 | main subject | adenocarcinoma | Q356033 |
| P577 | publication date | 2018-06-11 | |
| P1433 | published in | Cancers | Q27722963 |
| P1476 | title | Emerging Therapies and Future Directions in Targeting the Tumor Stroma and Immune System in the Treatment of Pancreatic Adenocarcinoma. | |
| P478 | volume | 10 |
Search more.